Navigation Links
New Findings Published In Circulation: Heart Failure Show Potential Utility Of Cardioxyl's HNO Donors As Novel Treatments For Heart Failure
Date:10/28/2013

CHAPEL HILL, N.C., Oct. 28, 2013 /PRNewswire/ -- Cardioxyl Pharmaceuticals, Inc. announced today the publication of recent findings on the role of a novel pure nitroxyl (HNO) donor in enhancing cardiac function and hemodynamics. These findings, based upon analysis of preclinical and human clinical data from studies of CXL-1020, were published online October 9, 2013, in Circulation: Heart Failure, which is published by the American Heart Association.

"Patients with acute decompensated heart failure (ADHF) present with a complex and often life-threatening clinical syndrome – and new therapeutic advances remain scant. These published data demonstrate the functional improvement in myocardial performance produced by a novel pure HNO donor, and show first-in-human evidence for the potential utility of an HNO donor in heart failure," said Wilson "Bill" S. Colucci, M.D., Thomas J. Ryan Professor of Medicine and Chief of the Cardiovascular Medicine Section at Boston University Medical Center, who served as Chairman of the Steering Committee for the CXL-1020 Phase 2a clinical study.

The data published in Circulation: Heart Failure summarize study findings from two preclinical models as well as a clinical study examining the hemodynamic effects and safety of CXL-1020 at doses of 1–20 mg/kg/min in patients with advanced heart failure hospitalized for invasive hemodynamic monitoring. Investigators reported human data demonstrating that CXL-1020, a novel pure HNO donor, enhanced cardiac systolic function while reducing pulmonary capillary wedge pressure (PCWP) and arterial and venous tone without increasing heart rate. Consistent with the clinical data, direct contractile enhancement from CXL-1020 was observed in isolated myocytes as well as in vivo in experimental canine he
'/>"/>

SOURCE Cardioxyl Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ARUP Laboratories Presents Recent Findings at PAINWeek
2. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
3. Key Findings: Innovations in Ophthalmic Devices - Anterior Segment
4. Oramed Pharmaceuticals to Present Findings on Oral Insulin to the American Diabetes Association
5. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
6. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
7. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
8. Managed Health Care Associates, Inc. (MHA) Released Results of Sixth Annual Independent Long Term Care Member Study with Expanded Specialty Pharmacy Findings
9. Dr. Kevin Foley to Present DiscGenics Recent Findings at the Lumbar Spine Research Societys Annual Meeting
10. Professional Therapy Associates Study Supports Findings: Physical Therapy Beneficial in Treating Office Workers with Lower Back Pain
11. HemoShear to Present Translational Findings from its Vascular and Liver Human Relevant Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... -- IRIDEX Corporation (Nasdaq: IRIX ) today reported financial ... 2015.  , Revenues were $11.8 million in the ... up 11% from $10.6 million in the 2013 fourth quarter. ... 12% from $38.3 million in 2013. , Gross margin ... in the fourth quarter of the prior year. , ...
(Date:3/5/2015)... 5, 2015 Bayer HealthCare announced today that ... Cancer Foundation of the American Society of Clinical Oncology ... technology platform designed to unlock vast quantities of information ... "Bayer is proud to join ASCO and ... Big Data to help people whose lives have been ...
(Date:3/5/2015)...   AMC Health , the leading provider ... the effectiveness and efficiency of healthcare for high-risk ... and Jared Wilstead have joined the ... Client Development, and Wilstead will serve as Vice ... commitment to accelerating the adoption of monitored care ...
Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3
... 2010 Mederi Therapeutics Inc announced today that it ... and use of Mederi,s second generation of the Stretta ... of gastric reflux disease, commonly known as GERD, and ... disorder, or BCD.  These latest systems include a streamlined ...
... 8, 2010 DURECT Corporation (Nasdaq: DRRX ... CEO, will be presenting at the Credit Suisse 2010 ... Pacific Time. The conference is being held at the ... ) (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) ...
Cached Medicine Technology:Mederi Therapeutics Announces Receipt of CE Mark for its Second Generation Secca® and Stretta® Systems 2
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market ... 7.8% from 2014 to 2019. , The global digital PCR (dPCR) ... 7.8% from 2014 to 2019. Although the mature markets such as ... digital PCR (dPCR) and qPCR market the Asia-Pacific region is expected ... period. The growth of the digital PCR (dPCR) and qPCR market ...
(Date:3/5/2015)... 05, 2015 Risperdal lawsuits ( ... Pennsylvania mass tort litigation currently underway in the ... has begun hearing testimony in the proceeding’s second ... medication can cause gynecomastia, or male breast growth. ... was filed on behalf of a plaintiff who ...
(Date:3/5/2015)... The Maricopa Community Colleges add $7.3 ... economy each year, according to a research report released ... Maricopa County Community College District, summarizes economic impact and ... year 2013-2014. , The analysis was conducted by ... that specializes in providing economic impact studies and labor ...
(Date:3/5/2015)... At the 7th Annual Mississippi Addiction Conference ... met today in Jackson, Mississippi to listen to keynote ... numerous respected speakers will be William S. Jacobs, ... pain medications have had in today’s opiate overdose and ... is hard to believe that much of the current ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Taking ... in Fort Worth, Texas April 9-11th is IDRevolution ... company providing personalized nutrition. IDLife offers a ... IDNutrition. This customized approach to vitamin supplementation ... begins with a free HIPAA compliant online assessment ...
Breaking Medicine News(10 mins):Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2
... explanations, study finds , TUESDAY, March 30 (HealthDay News) -- ... trials, most do not receive a clear explanation of their ... report suggests. , In the study, U.S. researchers interviewed 37 ... that more than half of them did not know or ...
... benefit more if they sought advice from doctors, pharmacists, study ... person with knee pain who learns that the cause is ... do the right things to treat it, and probably won,t ... , "Most of the things they did were appropriate," said ...
... ... ... -- Those with aching backs might want to look at their home décor to help ... price range, but many don,t take time to consider products that can actually benefit their ...
... ... ... media company for people who want to live well and do good, today announced three ... YouTube), Jill Beraud (Chief Marketing Officer of Pepsi Americas Beverages & President, Joint Ventures) and ...
... ... , ... 30, 2010 -- Tahitian Noni International (TNI) announced that their 2011 International ... of the Seas, one of the most luxurious cruise ships in the world. The announcement ...
... ... brought over 35 years of experience in industrial fabricating to the medical field. Midbrook ... tables, as well as cleaning and decontamination equipment. , ... (Vocus) March 30, 2010 -- Midbrook, the Jackson, ...
Cached Medicine News:Health News:Many Kids Not Fully Informed of Their Role in Cancer Studies 2Health News:Many With Arthritis Find Simple Solutions for Relief 2Health News:Proper Home Dcor May Assist in Alleviating Back Pain 2Health News:Proper Home Dcor May Assist in Alleviating Back Pain 3Health News:GOOD Adds Depth to Advisory Board 2Health News:Caribbean Cruise Announced by Tahitian Noni International for 2011 2Health News:Midbrook Medical Brings Industrial Experience to Medical Fabrication 2Health News:Midbrook Medical Brings Industrial Experience to Medical Fabrication 3
... TANGO is designed for ... services, donor centers and ... testing and antibody screening. ... host of functions including ...
The ScanGel® automatic readings are done with a high resolution color video camera. Images can be stored and printed....
... Since the early 1990s, the "Reversed" shoulder ... surgeons with great success. More recently, an ... States have begun to champion this prosthesis ... with it. This reversed technology is the ...
... SPEX Fluorolog-3, a spectro-fluorometer ... JOBIN YVON), is a new ... tailored combination of various components. ... customers to freely choose components ...
Medicine Products: